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Adipose tissue as a source of inflammatory cytokines in health systems, focusing mainly on adipocyte secretory products
and disease: Focus on end-stage renal disease. Adipose tissue that are collectively defined “adipokines,” (i.e., cytokines
is a necessary survival characteristic of species that do not have that are synthesized [either exclusively or not] in fatconstant access to food. TNF- is a very fundamental “internal
cells), the ultimate goal being that of focusing on a situa-regulator” (intra-system) of adipose tissue metabolism, and
tion opposite to obesity (i.e., on starvation and on theIL-6 and IL-1 are relevant control factors, as well. Leptin and
IL-6, but not TNF-, appear to be the major signals linking adverse effects of disordered adipokine regulation in
adipose tissue to the systemic immunologic response. In ESRD, patients with chronic renal diseases).
it has been coherently observed that acute-phase reactants like
CRP and serum amyloid A are independently associated to
atherosclerosis, death, and cardiovascular complications. Lep- EVOLUTIONARY IMPORTANCE OF
tin is inversely related with plasma creatinine, suggesting that INFLAMMATION AND INSULIN RESISTANCE
reduced renal clearance is a primary factor responsible for
The adipose tissue is a necessary survival characteristichyperleptinemia in ESRD. On the other hand, this adipose
tissue hormone behaves as an inverse acute-phase reactant of species without constant access to food. Humans de-
(i.e., it decreases during spontaneous episodes of the acute- veloped the ability to store fat for periods of famine.
phase response). Dialysis patients with hyperleptinemia have We now have virtually unlimited access to food andmore severe degrees of insulin resistance but further studies
accumulate excess energy for no useful purpose. A simi-are required to see whether leptin plays a role in insulin resis-
lar reasoning is applicable for energy output. We regulatetance in these patients.
The most abundant protein synthesized in the adipose tissue, energy output voluntarily by physical exercise and inac-
adiponectin, is inversely related to metabolic risk factors like tivity is recognized as an important cause of obesity.
glucose, triglycerides, insulin, and HDL cholesterol in uremic Besides famine, infection was the other major threat for
patients, suggesting that this cytokine is a protective factor for
survival of prehistoric man. A wide array of genes inthe cardiovascular system. Accordingly, plasma adiponectin is
the human genome are committed to two integratedan independent, inverse predictor of incident cardiovascular
events in dialysis patients. problems: a) the inflammatory response to survive
trauma, infection, and other threats to organ integrity;
and b) the metabolic adaptation to scarce energy input
during periods of food deprivation. These evolutionaryOn a world scale obesity and overweight represent a
pressures selected individuals able to mount efficaciousspiraling problem in the Western, affluent society, and
inflammatory responses and an “energy-sparing” meta-it is expected that in two decades, increasing prosperity
bolic attitude (i.e., insulin resistance). Primitive man hadwill also bring the burden of these diseases to developing
a very active lifestyle, and atherosclerosis and insulincountries. The dimensions of this health problem have
resistance did not represent health problems for our pro-driven great intellectual and financial resources on the
genitors. In our era, sedentary habits, food abundance,study of biology of adipose tissue. The returns of these
and the reduced infection death toll have paved the wayresearch investments go far beyond obesity and span
to the epidemic of insulin resistance syndrome, diabetes,from cancer to cardiovascular disease. In this brief re-
and atherosclerotic complications.view, we will discuss recent progress in the understanding
of the integration of adipose tissue with other organ
INFLAMMATION AND THE CYTOKINE
SYSTEM OF THE ADIPOSE TISSUEKey words: adipose tissue, leptin, adiponectin, cytokines, IL-6, TNF-,
cardiovascular risk, nutrition, ESRD, uremia, dialysis. The immunologic system burns up about 15% of rest-
ing metabolic rate and therefore it represents a major 2003 by the International Society of Nephrology
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energy-consumer among human organ systems. Such a dant adipose tissue-derived plasma protein, expanded
knowledge of adipocyte proteins. The relationship ofhigh consumption clearly requires adequate sources of
energy, and the adipose tissue appears well equipped to this protein with fat and body mass is opposite to that
of leptin; adiponectin is significantly reduced in obeseprovide such a high-energy input. The metabolic poten-
tial of adipose tissue and the energy needs of the immune subjects in comparison to lean, healthy control subjects
[9]. Like plasma leptin, adiponectin plasma concentra-system have probably led to evolutionary development
of feedback relationships between the two systems. Thus, tion also appears to be sex-dependent [10]. Adiponectin
is emerging as a pleiotropic cytokine linked not only towhen the immune system is challenged, an important
flow of energy is required. As a result, cytokines like fat mass and energy balance but also to other fundamen-
tal body functions like hematopoiesis and immunity [11].TNF- are recruited to induce lipolysis [1] and to mobi-
lize energy. Conversely, when adipose tissue stores are
depleted, energy sparing becomes a priority, even at the
ADIPOKINES IN END-STAGE RENAL DISEASE
cost of imposing a decrease in the level of immunologic
(ESRD): THE ACUTE-PHASE RESPONSE,
surveillance. Therefore, in this situation, switching off
LEPTIN, AND ADIPONECTIN
the immune response would appear to be an appropriate
During evolution, organisms developed the acute-counter-regulatory response. Cachexia is indeed associ-
phase response so as to localize and limit the injury andated with a significant impairment of cell-mediated im-
to clear necrotic products, and to confine the effects ofmunity, phagocyte function, complement factors, and
the original insult. An important part of this defensivecytokine production. TNF- is a very fundamental “in-
response involves C-reactive protein and complement.ternal regulator” of adipose tissue metabolism, and IL-6
This response is orchestrated by cytokines like TNF-,and IL-1 are relevant control factors, as well. Indeed,
IL-1, IL-6, and other pro-inflammatory cytokines, whichboth TNF- and IL-6 [2] inhibit lipoprotein lipase, while
are produced both by immunocompetent cells and byTNF- down-regulates insulin-dependent glucose up-
other cells (e.g., cardiomyocytes in the heart or smoothtake via glucose transporter 4 and insulin receptor auto-
muscle cells, or endothelial cells in the vascular system).phosphorylation, thus modulating lipid accumulation.
The predominant effects of these proteins are local, atEstablished inflammation-triggers like lipopolysac-
the site of injury, but these cytokines also have systemiccharides are able to stimulate the synthesis and the re-
effects. IL-6 is the cytokine with the longest serum half-lease of cytokines from adipocytes, but factors responsi-
life and with the most well-defined endocrine effects.ble for the regulation of these substances in the adipose
Although the cause(s) of cachexia in ESRD are incom-tissue are still not completely understood. TNF- has
pletely understood, evidence is emerging that this com-well-defined effects on adipocyte trophism in that it con-
plication is multifactorial, and that inflammation is atrols cell size and may induce apoptosis. Furthermore,
prominent correlate of it [12]. The acute-phase responsethis cytokine has a biphasic action on leptin secretion
has nutritional implications because it is energy-intensive(initial stimulation followed by suppression) [3], and in-
and requires large quantities of essential amino acids.hibits the expression of 3 receptors. The effect of TNF-
When this process goes unabated, the inflammatory re-on 3 receptors is of relevance because these receptors
sponse is no longer protective and inflammation becomesmediate sympathetically-mediated lipolysis in white adi-
a strong risk factor for mortality and cardiovascular com-pose cells and thermogenesis in brown adipose tissue [4].
plications. The relationship between acute-phase re-Notwithstanding, the dominant regulatory role of
actants/cytokines and all-cause and cardiovascular mor-TNF- within the adipose tissue, leptin, and IL-6, but
tality has been intensively investigated in patients withnot TNF-, appears to be the major signals linking the
ESRD. It has been coherently observed that acute-phaseadipose tissue to systemic immunologic response. To
reactants like CRP are independently associated to ath-date there is no evidence that TNF- is released systemi-
erosclerosis [13], death, and cardiovascular complica-cally by the adipose tissue, while it is well established
tions [14, 15]. IL-6 correlates with the severity of athero-that leptin [5] and IL-6 [6] have important effects on
sclerosis [16], and high TNF-, IL-1, and IL-6 arethe hypothalamus, where they suppress appetite. IL-6
associated with shorter survival [17] in dialysis patients.promotes the synthesis of C-reactive protein and other
It is presently unknown whether cytokines generatedacute-phase proteins in the liver, while leptin modulates
in the adipose tissue in uremic patients contribute toinsulin secretion in the pancreas [7]. Furthermore, leptin
systemic complications.is strictly related to body fat and sex, and has a variety of
Probably due to its anorexigen effect, leptin is theactions, which span from interference with sympathetic
most studied adipokine in ESRD. In ESRD, abolishedactivity to hematopoiesis and reproductive function [8].
renal clearance is the primary factor responsible for hyp-In 1996, the discovery of adiponectin, a collagen-like
erleptinemia, and in uremic patients, the physiologic re-protein of the collectin family that is synthesized exclu-
sively in the adipose tissue and which is the most abun- lationship between leptin and the BMI is shifted to the
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Fig. 2. Direct relationship between leptin and the HOMA index in
dialysis patients (hemodialysis N  228, CAPD  51) in the CREED
study (Cardiovascular Risk Extended Evaluation in Dialysis patients).Fig. 1. Relationship between adiponectin and leptin. Data are median
The relationship between leptin and the HOMA index remained sig-values and interquartile ranges.
nificant also after adjustment for the BMI (partial r  0.24, P  0.01).
right in comparison to that in healthy subjects [18]. On
2). This phenomenon suggests that factors other than
the other hand, the ob gene is overexpressed in uremic
abolished renal function play a role in the regulation ofpatients with high CRP, suggesting that inflammation
the plasma concentration of these substances in uremicmay contribute to hyperleptinemia [19]. Yet careful ob-
patients. In our study, adiponectin was unrelated to CRP,servations by Don et al [20] demonstrated that leptin
but serial measurements during intercurrent episodes ofbehaves as an inverse acute-phase reactant (i.e., plasma
inflammation will be required to prove that that thisleptin decreases) during spontaneous episodes of the
cytokine is truly “inflammation-insensitive.”acute-phase response, a phenomenon presumably due
Interest on adiponectin derives from its potential pro-to a simultaneous, inflammation-induced, decrease in
tective role for the cardiovascular system. AdiponectinIGF-1. Another important reason for the interest in lep-
inhibits TNF-–induced monocyte adhesion and adhe-tin in ESRD depends on its direct link with plasma insu-
sion molecule expression in vitro, and modulates thelin and on its inverse association with erythropoietin
endothelial response to inflammatory stimuli [22]. In linedose. The relationship between leptin and insulin is also
with this hypothesis, it has been recently reported thatconfirmed in the Cardiovascular Risk Extended Evalua-
adiponectin is reduced in patients with coronary hearttion in Dialysis (CREED) study cohort. Indeed, in this
disease [22] and in type 2 diabetics [9], in which thestudy leptin was directly related to plasma insulin, as
plasma concentration of this protein tends to be inverselywell as to the HOMA index (a measure of insulin sensi-
related to the severity of cardiovascular damage. Athero-tivity) (Fig. 1). Of note, the link between leptin and this
sclerosis is an inflammatory disease and inflammationindex was largely independent of BMI and other risk
(as quantified by CRP) is an independent marker of thefactors. Leptin is an independent predictor of adverse
severity of atherosclerosis in uremic patients [13]. If thecardiovascular events in the general population. Because
inflammatory response detected in atherosclerotic le-leptin has no direct atherogenic properties, this data may
sions is counteracted in vivo by adiponectin, this proteinsimply indicate that the plasma concentration of this
may have a role for the prevention and/or the retardationprotein may be a risk marker. To date, no study in uremic
of atherogenesis in various diseases, including chronicpatients has explored whether leptin predicts survival
renal failure. The multiple links of adiponectin to severaland cardiovascular events in ESRD.
metabolic risk factors like glucose, triglycerides, insulin,Adiponectin has been investigated little in patients
and HDL cholesterol in uremic patients [21] are all co-with chronic renal diseases. We have shown that, inde-
herently in line with the hypothesis that adiponectin ispendent of treatment modality and diabetes, the plasma
a protective factor. In this regard, it is of great interestconcentration of this adipokine is markedly raised in
that plasma adiponectin is an inverse predictor of inci-dialysis patients, and that it is related to several funda-
dent cardiovascular events in dialysis patients, and thatmental metabolic fuels and hormones like glucose, insu-
this link is independent of traditional and nontraditionallin, and triglycerides [21]. Though adiponectin and leptin
risk factors (36). However, adiponectin was much in-are both markedly increased in dialysis patients, the two
hormones are inversely, rather than directly, related (Fig. creased (20.8  6.8 g/mL), not only in patients with a
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